1,032
Views
0
CrossRef citations to date
0
Altmetric
Licensed Vaccines – Research Paper

Evaluating the impact of universal varicella vaccination among preschool-aged children in Qingdao, China: An interrupted time-series analysis

, , , & ORCID Icon
Article: 2094641 | Received 30 Apr 2022, Accepted 18 Jun 2022, Published online: 12 Jul 2022

References

  • Choo PW, Donahue JG, Platt MR. The epidemiology of varicella and its complications. J Infect Dis. 1995;172(3):1–6. doi:10.1093/infdis/172.3.706.
  • Varicella and herpes zoster vaccines: WHO position paper, June 2014–recommendations. Vaccine. 2016;34(2):198–199. doi:10.1016/j.vaccine.2014.07.068.
  • Siu HT, Wang LJ, M LY, Yin DP. Varicella epidemiology in China, 2005-2015. Chin J Vaccines Immun. 2019;25:155–159.
  • Dong Pumei WM, Yanmin L. Epidemiological characteristics of varicella in China, 2016-2019. Chin J Vaccines Immun. 2020;26:403–406.
  • Wang Y, et al. Effectiveness and failure rate of the varicella vaccine in an outbreak in Jiangsu, China: a 1:2 matched case-control study. Hum Vaccin Immunother. 2019;16(3):506–512.
  • Hu P, Yang F, Li X, Wang Y, Xiao T, Li H, Wang W, Guan J, Li S. Effectiveness of one-dose versus two-dose varicella vaccine in children in Qingdao, China: a matched case-control study. Hum Vaccin Immunother. 2021;17(12):5311–5315. doi:10.1080/21645515.2021.1982281.
  • Shapiro ED, Vazquez M, Esposito D, Holabird N, Steinberg SP, Dziura J, LaRussa PS, Gershon AA. Effectiveness of 2 doses of varicella vaccine in children. J Infect Dis. 2011;203(3):312–315. doi:10.1093/infdis/jiq052.
  • Suo L, Lu L, Zhao D, Pang X. Impact of a 2-dose voluntary vaccination strategy on varicella epidemiology in Beijing, 2011–2017. Vaccine. 2020;38(20):3690–3696. doi:10.1016/j.vaccine.2020.01.087.
  • Xu Y, et al. Epidemiology of varicella and effectiveness of varicella vaccine in Hangzhou, China, 2019. Hum Vaccin Immunother. 2020;17(1):211–216.
  • Wu QS, Liu J-Y, Wang X, Chen Y-F, Zhou Q, Wu A-Q, Wang L. Effectiveness of varicella vaccine as post-exposure prophylaxis during a varicella outbreak in Shanghai, China. Int J Infect Dis. 2018;66:51–55. doi:10.1016/j.ijid.2017.10.016.
  • Chan YD, Edmunds WJ, Chan H-L, Wong M-L, Au KWA, Chuang S-K, van Hoek AJ, Flasche S. Varicella vaccine dose depended effectiveness and waning among preschool children in Hong Kong. Hum Vaccin Immunother. 2020;16(3):499–505. doi:10.1080/21645515.2019.1663121.
  • Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther. 2002;27(4):299–309. doi:10.1046/j.1365-2710.2002.00430.x.
  • Kawamura Y, Hattori F, Higashimoto Y, Kozawa K, Yoshikawa T. Evaluation of varicella vaccine effectiveness during outbreaks in schools or nurseries by cross-sectional study. Vaccine. 2021;39(21):2901–2905. doi:10.1016/j.vaccine.2021.04.009.
  • Soumerai SB, Starr D, Majumdar SR. How do you know which health care effectiveness research you can trust? a guide to study design for the perplexed. Prev Chronic Dis. 2015;12:E101. doi:10.5888/pcd12.150187.
  • Penfold RB, Zhang F. Use of interrupted time series analysis in evaluating health care quality improvements. Acad Pediatr. 2013;13(6 Suppl):S38–44. doi:10.1016/j.acap.2013.08.002.
  • Kontopantelis E, Doran T, Springate DA, Buchan I, Reeves D. Regression based quasi-experimental approach when randomisation is not an option: interrupted time series analysis. Bmj. 2015;350:h2750. doi:10.1136/bmj.h2750.
  • Marin M, et al. Global varicella vaccine effectiveness: a meta-analysis. Pediatrics. 2016;137(3):e20153741. doi:10.1542/peds.2015-3741.
  • Henry O, et al. One or two doses of live varicella virus-containing vaccines: efficacy, persistence of immune responses, and safety six years after administration in healthy children during their second year of life. Vaccine. 2018;36(3):381–387. doi:10.1016/j.vaccine.2017.11.081.
  • Seward JF, Marin M, Vázquez M. Varicella vaccine effectiveness in the US vaccination program: a review. J Infect Dis. 2008;197(2):S82–9. doi:10.1086/522145.
  • Hao B, Chen Z, Zeng G, Huang L, Luan C, Xie Z, Chen J, Bao M, Tian X, Xu B, et al. Efficacy, safety and immunogenicity of live attenuated varicella vaccine in healthy children in China: double-blind, randomized, placebo-controlled clinical trial. Clin Microbiol Infect. 2019;25(8):1026–1031. doi:10.1016/j.cmi.2018.12.033.
  • Vázquez M, et al. Effectiveness over time of varicella vaccine. Jama. 2004;291(7):851–855. doi:10.1001/jama.291.7.851.
  • Hong K, Sohn S, Choe YJ, Rhie K, Lee JK, Han MS, Chun BC, Choi EH. Waning effectiveness of one-dose universal varicella vaccination in Korea, 2011–2018: a propensity score matched national population cohort. J Korean Med Sci. 2021;36(36):e222. doi:10.3346/jkms.2021.36.e222.
  • Duncan JR, et al. Varicella seroepidemiology in United States air force recruits: a retrospective cohort study comparing immunogenicity of varicella vaccination and natural infection. Vaccine. 2017;35(18):2351–2357. doi:10.1016/j.vaccine.2017.03.054.
  • Leung J, Broder KR, Marin M. Severe varicella in persons vaccinated with varicella vaccine (breakthrough varicella): a systematic literature review. Expert Rev Vaccines. 2017;16(4):391–400. doi:10.1080/14760584.2017.1294069.
  • Kurugöl Z, Gökçe Ş. Outbreak of varicella in preschool children despite one-dose vaccination. Turk J Pediatr. 2018;60(1):56–62. doi:10.24953/turkjped.2018.01.008.
  • Holl K, et al. Coverage, efficacy or dosing interval: which factor predominantly influences the impact of routine childhood vaccination for the prevention of varicella? a model-based study for Italy. BMC Public Health. 2016;16(1):1103. doi:10.1186/s12889-016-3738-x.
  • Avila-Aguero ML, Ulloa-Gutierrez R, Camacho-Badilla K, Soriano-Fallas A, Arroba-Tijerino R, Morice-Trejos A. Varicella prevention in Costa Rica: impact of a one-dose schedule universal vaccination. Expert Rev Vaccines. 2017;16(3):229–234. doi:10.1080/14760584.2017.1247700.
  • Hecht J, Siedler A. [The epidemiology of varicella disease in Germany after introduction of a vaccination recommendation : analysis of mandatory and sentinel data between 2002 and 2014]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2017;60(1):118–126. doi:10.1007/s00103-016-2475-8.
  • Khandaker G, Marshall H, Peadon E, Zurynski Y, Burgner D, Buttery J, Gold M, Nissen M, Elliott EJ, Burgess M, et al. Congenital and neonatal varicella: impact of the national varicella vaccination programme in Australia. Arch Dis Child. 2011;96(5):453–456. doi:10.1136/adc.2010.206037.
  • Doll MK, Rosen JB, Bialek SR, Szeto H, Zimmerman CM. An evaluation of voluntary 2-dose varicella vaccination coverage in New York City public schools. Am J Public Health. 2015;105(5):972–979. doi:10.2105/AJPH.2014.302229.
  • Zeng WB, Zhang F, Cheng S, Sun J-Y, Shen H, Luo M-H. Concerns on vaccine against varicella caused by varicella-zoster virus infection. Virol Sin. 2021;36(1):159–162. doi:10.1007/s12250-020-00231-4.
  • Beleni AI, Borgmann S. Mumps in the vaccination age: global epidemiology and the situation in Germany. Int J Environ Res Public Health. 2018;15(8):1618. doi:10.3390/ijerph15081618.
  • Li Z, Yao Y, Lu X, Liu J, Huang Z, Sun X, Lu Y. Impact of a two-dose varicella immunization program on the incidence of varicella: a multi-year observational study in Shanghai, China. Expert Rev Vaccines. 2021;20(9):1177–1183. doi:10.1080/14760584.2021.1963236.
  • Li Xiaofan XX, Wencheng W, Tingting X, Feng Y. Epidemiological characteristics of varicella public health emergency events in Qingdao city, 2006-2019. Chin J Vaccines Immun. 2020;26:283–286.